Tumor Necrosis Factor α Inhibitor-Induced Alopecia in Pediatric Patients: A Cohort of 20 Patients and Review of the Literature
June 2025
in “
Archives of Dermatological Research
”
TLDR Stopping TNFα inhibitors can help children regrow hair lost due to the medication.
A study involving 20 pediatric patients (mean age 12.9 years) treated with TNFα inhibitors revealed that drug-induced alopecia is a rare but notable adverse event, primarily affecting adolescents with inflammatory bowel diseases. The study found that 90% of patients developed psoriatic-like inflammatory alopecia, and 85% discontinued TNFα therapy, resulting in hair regrowth within six months. The findings suggest that cessation of TNFα inhibitors is necessary to improve alopecia outcomes in affected children. The study's results align with existing literature, highlighting the importance of monitoring and managing this side effect in pediatric patients.